1. Generic drugs: Stakeholder views on improving FDA’s information on patents : report to congressional committees Publication: Washington, DC : United States Government Accountability Office, March 2023 Subject(s): Drugs, Generic -- economicsDrug Development -- legislation & jurisprudenceGovernment RegulationLegislation, MedicalPatents as Topic -- legislation & jurisprudencePrescription Fees -- legislation & jurisprudenceUnited States
